These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31921059)

  • 21. Do we need a vaccine against chikungunya?
    Rezza G
    Pathog Glob Health; 2015 Jun; 109(4):170-3. PubMed ID: 25971340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chikungunya Vaccine Candidates: Current Landscape and Future Prospects.
    Schmidt C; Schnierle BS
    Drug Des Devel Ther; 2022; 16():3663-3673. PubMed ID: 36277603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chikungunya vaccines in development.
    Schwameis M; Buchtele N; Wadowski PP; Schoergenhofer C; Jilma B
    Hum Vaccin Immunother; 2016 Mar; 12(3):716-31. PubMed ID: 26554522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits.
    Metz SW; Martina BE; van den Doel P; Geertsema C; Osterhaus AD; Vlak JM; Pijlman GP
    Vaccine; 2013 Dec; 31(51):6092-6. PubMed ID: 24099875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutating chikungunya virus non-structural protein produces potent live-attenuated vaccine candidate.
    Chan YH; Teo TH; Utt A; Tan JJ; Amrun SN; Abu Bakar F; Yee WX; Becht E; Lee CY; Lee B; Rajarethinam R; Newell E; Merits A; Carissimo G; Lum FM; Ng LF
    EMBO Mol Med; 2019 Jun; 11(6):. PubMed ID: 31015278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro.
    von Rhein C; Weidner T; Henß L; Martin J; Weber C; Sliva K; Schnierle BS
    Antiviral Res; 2016 Jan; 125():51-7. PubMed ID: 26611396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next generation sequencing of DNA-launched Chikungunya vaccine virus.
    Hidajat R; Nickols B; Forrester N; Tretyakova I; Weaver S; Pushko P
    Virology; 2016 Mar; 490():83-90. PubMed ID: 26855330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by
    Delang L; Yen PS; Vallet T; Vazeille M; Vignuzzi M; Failloux AB
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection.
    Weber C; Sliva K; von Rhein C; Kümmerer BM; Schnierle BS
    Antiviral Res; 2015 Jan; 113():1-3. PubMed ID: 25446334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chikungunya Virus-Induced Arthritis: Role of Host and Viral Factors in the Pathogenesis.
    Amdekar S; Parashar D; Alagarasu K
    Viral Immunol; 2017 Dec; 30(10):691-702. PubMed ID: 28910194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system.
    Wu J; Zhao C; Liu Q; Huang W; Wang Y
    Vaccine; 2017 Nov; 35(47):6387-6394. PubMed ID: 29031692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Virus-Like Particle Vaccine Elicits Broad Neutralizing Antibody Responses in Humans to All Chikungunya Virus Genotypes.
    Goo L; Dowd KA; Lin TY; Mascola JR; Graham BS; Ledgerwood JE; Pierson TC
    J Infect Dis; 2016 Nov; 214(10):1487-1491. PubMed ID: 27655868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Overview of Indian Biomedical Research on the Chikungunya Virus with Particular Reference to Its Vaccine, an Unmet Medical Need.
    Varikkodan MM; Kunnathodi F; Azmi S; Wu TY
    Vaccines (Basel); 2023 Jun; 11(6):. PubMed ID: 37376491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate.
    Saraswat S; Athmaram TN; Parida M; Agarwal A; Saha A; Dash PK
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004782. PubMed ID: 27399001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review.
    Lo Presti A; Cella E; Angeletti S; Ciccozzi M
    Infect Genet Evol; 2016 Jul; 41():270-278. PubMed ID: 27085290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-Wide Approaches to Unravel the Host Factors Involved in Chikungunya Virus Replication.
    Tanaka A; Suzuki Y
    Front Microbiol; 2022; 13():866271. PubMed ID: 35401487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate.
    Plante KS; Rossi SL; Bergren NA; Seymour RL; Weaver SC
    PLoS Negl Trop Dis; 2015; 9(9):e0004007. PubMed ID: 26340754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A safe insect-based Chikungunya fever vaccine affords rapid and durable protection in cynomolgus macaques.
    Adam A; Woolsey C; Lu H; Plante K; Wallace SM; Rodriguez L; Shinde DP; Cui Y; Franz AWE; Thangamani S; Comer JE; Weaver SC; Wang T
    bioRxiv; 2024 May; ():. PubMed ID: 38826312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology.
    Eldi P; Cooper TH; Liu L; Prow NA; Diener KR; Howley PM; Suhrbier A; Hayball JD
    Mol Ther; 2017 Oct; 25(10):2332-2344. PubMed ID: 28720468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a Specific CHIKV-E2 Monoclonal Antibody for Chikungunya Diagnosis.
    Kim J; Yang J; Kim YB; Lee HJ; Kim S; Poo H
    Virol Sin; 2019 Oct; 34(5):563-571. PubMed ID: 31214999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.